The Board remands the claim for service connection for cause of death due to acute myelogenous leukemia, as there are outstanding private treatment records and an inadequate VA medical opinion.
The deciding factor: Remand is necessary to correct pre-decisional duty-to-assist errors, including obtaining additional evidence and providing addendum opinions.
- Claimed conditions
- Acute myelogenous leukemia (AML)
- How they argued it
- Direct service connection
- Exposure basis
- Agent Orange / herbicides
- Rating
- Not verified here — check the original decision
- Decision date
- November 18, 2025
- Citation
- A25099924
Veterans Law Judge
Decisions by this judge: 1,812 · Granted: 30% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A25099924.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has granted the appeals to sever service connection for bladder cancer, acute myelogenous leukemia (AML), and a dental condition secondary to AML. The reasons given are that there was no clear and unmistakable error in granting these conditions of service connection.
- Whole decision: Granted
The Board granted service connection for the cause of the Veteran's death, for purposes of receiving DIC, based on a finding that his AML was related to in-service herbicide exposure and contributed substantially to his death.
- Whole decision: Remanded (sent back)
The Board remands the matter for a medical opinion to determine if the Veteran's acute myelogenous leukemia was related to his service, including potential exposures to benzene and Agent Orange.
- Whole decision: Partly granted
The Veteran was granted a 100 percent rating for acute myelogenous leukemia (AML) from January 22, 2016, to October 31, 2017, and a noncompensable rating from November 1, 2017. The Veteran's earlier effective dates for the grants of service connection for hemorrhoids, anal fissures, pruritus ani, skin disability, and eye disability were also granted.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.